Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Active surveillance for low-risk prostate cancer.
Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. Bangma CH, et al. Among authors: parker c. Crit Rev Oncol Hematol. 2013 Mar;85(3):295-302. doi: 10.1016/j.critrevonc.2012.07.005. Epub 2012 Aug 9. Crit Rev Oncol Hematol. 2013. PMID: 22878262 Review.
This paper reflects the consensus on the state of the art and the future direction of AS, based on the Inside Track Conference "Active Surveillance for low risk prostate cancer" (Chairmen: C.H. Bangma, NL, and L. Klotz, CA; Co-Chairmen: L.J. Denis, BE, and C. Par …
This paper reflects the consensus on the state of the art and the future direction of AS, based on the Inside Track Conference "Active Surve …
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
Ahmed HU, Akin O, Coleman JA, Crane S, Emberton M, Goldenberg L, Hricak H, Kattan MW, Kurhanewicz J, Moore CM, Parker C, Polascik TJ, Scardino P, van As N, Villers A; Transatlantic Consensus Group on Active Surveillance and Focal Therapy for Prostate Cancer (appendix). Ahmed HU, et al. Among authors: parker c. BJU Int. 2012 Jun;109(11):1636-47. doi: 10.1111/j.1464-410X.2011.10633.x. Epub 2011 Nov 11. BJU Int. 2012. PMID: 22077593 Free PMC article.
Active surveillance for prostate cancer: a systematic review of the literature.
Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS. Dall'Era MA, et al. Among authors: parker c. Eur Urol. 2012 Dec;62(6):976-83. doi: 10.1016/j.eururo.2012.05.072. Epub 2012 Jun 7. Eur Urol. 2012. PMID: 22698574 Review.
Prostate cancer: ESMO Consensus Conference Guidelines 2012.
Horwich A, Hugosson J, de Reijke T, Wiegel T, Fizazi K, Kataja V; Panel Members; European Society for Medical Oncology. Horwich A, et al. Ann Oncol. 2013 May;24(5):1141-62. doi: 10.1093/annonc/mds624. Epub 2013 Jan 9. Ann Oncol. 2013. PMID: 23303340 Free article.
Can we deliver randomized trials of focal therapy in prostate cancer?
Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M; Prostate Cancer RCT Consensus Group. Ahmed HU, et al. Among authors: parker c. Nat Rev Clin Oncol. 2014 Aug;11(8):482-91. doi: 10.1038/nrclinonc.2014.44. Epub 2014 Apr 22. Nat Rev Clin Oncol. 2014. PMID: 24751803 Review.
3,104 results